Crenezumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Crenezumab Usage And Synthesis

Uses

Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1].

References

[1] S Zampar, et al. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease. Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685. DOI:10.1111/nan.12637

Crenezumab(1095207-05-8)Related Product Information

• Ontamalimab
• Alomfilimab
• Lacnotuzumab
• Xentuzumab
• Bleselumab
• Sirexatamab
• Voxalatamab
• Spartalizumab
• Abrezekimab
• Morolimumab